While drinking coffee has been occasionally associated with reduced risk of Parkinson’s disease, a new study suggests how and why that association may differ depending on the individual.
Researchers analyzing more than 435,000 UK Biobank participants found no significant link between coffee drinking and Parkinson’s risk across the population as a whole. Yet when participants were separated according to a common genetic variant that influences caffeine metabolism, sharply different patterns emerged.
The study, published Aug. 31 in the journal Parkinson’s Disease, followed adults who did not have Parkinson’s disease at the start of the study. Over a median of 15.7 years, 3,319 participants developed the disease.
Genetics and Caffeine Metabolism
The researchers focused on CYP1A2, a gene involved in breaking down caffeine in the liver. Participants were grouped according to a common variation in that gene associated with faster or slower caffeine metabolism.
Among people genetically classified as faster caffeine metabolizers, drinking less than 5 cups of coffee per day was associated with a 17% lower risk of Parkinson’s compared with drinking no coffee. The apparent benefit was greatest at about 3 cups per day.
The picture flipped among slower metabolizers. Drinking 5 or more cups per day was associated with a 43% higher Parkinson’s risk in one slower-metabolizing group and an 84% higher risk in the slowest group.
The authors also found differences between men and women. The lower-risk association among faster metabolizers was most apparent in women, while the higher risk among slower metabolizers appeared mainly in men. However, the statistical tests comparing those sex differences were not significant, so the authors cautioned against reading too much into them.
Some Clarity on Parkinson’s Risk
The findings may help explain why studies of coffee and Parkinson’s disease have not always produced the same results. Coffee and caffeine have been associated with lower Parkinson’s risk, but individual responses to caffeine vary substantially. One 2024 study also found that people were using coffee to self-treat Parkinson’s symptoms, but not talking to their doctors about it.
The new study was observational, meaning it cannot show that coffee caused either the lower or higher risks. Coffee consumption was self-reported only at the beginning of the study, and caffeinated and decaffeinated coffee were analyzed together.
The research was supported by the Shanghai Key Technology R&D Program, the National Natural Science Foundation of China and the Key Laboratory of Exercise and Health Sciences at Shanghai University of Sport. The authors declared no competing interests.
Comments? Questions? News to share? Contact DCN’s editors here. For all the latest coffee industry news, subscribe to the DCN newsletter.


Comment